Answer
Aug 19, 2026 - 11:48 AM
The success rate of Olumiant (baricitinib) varies depending on the condition being treated. In clinical trials for rheumatoid arthritis, about 60–70% of patients achieved significant improvement in symptoms. For alopecia areata, around 20–40% of patients achieved substantial hair regrowth after several months of treatment.
